The formation of new vessels (angiogenesis) is essential for primary tumour growth and metastasis and is induced by several angiogenic factors, including vascular endothelial growth factor (VEGF). The microvascular density (MVD) in tumours was assessed and the expression of VEGF and its receptors VE
Differential expression of the two VEGF receptors flt and KDR in placenta and vascular endothelial cells
✍ Scribed by Bernhard Barleon; Stefanie Hauser; Claudia Schöllmann; Karin Weindel; Dieter Marmé; Avner Yayon; Herbert A. Weich
- Publisher
- John Wiley and Sons
- Year
- 1994
- Tongue
- English
- Weight
- 996 KB
- Volume
- 54
- Category
- Article
- ISSN
- 0730-2312
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Background. Vascular endothelial growth factor (VEGF) is a specific endothelial cell mitogen that stimulates angiogenesis and plays a crucial role in tumor growth. The aim of the present study was to evaluate the expression of VEGF and of its two high-affinity tyrosine kinase receptors (KDR and Flt-
## Abstract Angiogenesis is essential in bone fracture healing for restoring blood flow to the fracture site. Vascular endothelial growth factor (VEGF) and its receptor have been implicated in this process. Despite the importance of angiogenesis for the healing processes of damaged bones, the role
Vascular Endothelial Growth Factor (VEGF) has been typically considered to be an endothelial-specific growth factor. However, it was recently demonstrated that VEGF can interact with non endothelial cells. In this study, we tested whether vascular smooth muscles cells (VSMCs) can express VEGF recept